Recombinant SLURP-1 Inhibits Growth and Migration of U251 MG Glioma by Cell Cycle Arrest and Modulation of MAPK and AKT Signaling Pathways

封面

如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

A recombinant analog of the human SLURP-1 protein (rSLURP-1) effectively inhibits the growth of carcinomas by interaction with the α7-type nicotinic acetylcholine receptor. Recently, rSLURP-1 inhibition of gliomas growth in vitro was shown by the authors, although, the mechanism of rSLURP-1 action was not studied. Here, we showed that rSLURP-1 selectively inhibits the growth of U251 MG glioma cells but not of normal astrocytes, and controls glioma cell migration. In addition, rSLURP-1 induces cell cycle arrest in the G2/M phase in U251 MG glioma cells, but does not result in apoptosis. Incubation of U251 MG cells with rSLURP-1 causes inhibition of phosphorylation of ERK, p38 MAPK, and AKT kinases, the activation of which contributes to the progression of gliomas. At the same time, rSLURP-1 does not affect the activity of JNK kinase. Thus, rSLURP-1 is an endogenous protein promising for the development of drugs based on it for the treatment of not only carcinomas, but also gliomas.

作者简介

M. Shulepko

Shenzhen MSU-BIT University, International University Park Road 1; Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences

Email: ekaterina-lyukmanova@yandex.ru
PRC, 518172, Guangdong Province, Shenzhen, Dayun New Town, Longgang District; Russia, 117997, Moscow, ul. Miklukho-Maklaya 16/10

M. Bychkov

Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences

Email: ekaterina-lyukmanova@yandex.ru
Russia, 117997, Moscow, ul. Miklukho-Maklaya 16/10

M. Kirpichnikov

Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences; Interdisciplinary Scientific and Educational School of Moscow University “Molecular Technologies of the Living Systems and Synthetic Biology”, Faculty of Biology, Lomonosov Moscow State University

Email: ekaterina-lyukmanova@yandex.ru
Russia, 117997, Moscow, ul. Miklukho-Maklaya 16/10; Russia, 119234, Moscow, Leninskiye Gory 1/12

E. Lyukmanova

Shenzhen MSU-BIT University, International University Park Road 1; Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences; Interdisciplinary Scientific and Educational School of Moscow University “Molecular Technologies of the Living Systems and Synthetic Biology”, Faculty of Biology, Lomonosov Moscow State University

编辑信件的主要联系方式.
Email: ekaterina-lyukmanova@yandex.ru
PRC, 518172, Guangdong Province, Shenzhen, Dayun New Town, Longgang District; Russia, 117997, Moscow, ul. Miklukho-Maklaya 16/10; Russia, 119234, Moscow, Leninskiye Gory 1/12

参考

  1. Cahill D., Turcan S. // Semin. Neurol. 2018. V. 38. P. 5–10. https://doi.org/10.1055/s-0037-1620238
  2. Hu Y., Jiang Y., Behnan J., Ribeiro M.M., Kalantzi C., Zhang M.D., Lou D., Häring M., Sharma N., Okawa S., Del Sol A., Adameyko I., Svensson M., Persson O., Ernfors P. // Sci. Adv. 2022. V. 8. P. eabm6340. https://doi.org/10.1126/sciadv.abm6340
  3. Ostrom Q.T., Gittleman H., Truitt G., Boscia A., Kruchko C., Barnholtz-Sloan J.S. // Neuro Oncol. 2018. V. 20. P. iv1–iv86. https://doi.org/10.1093/neuonc/noy131
  4. Tan A.C., Ashley D.M., López G.Y., Malinzak M., Friedman H.S., Khasraw M. // CA Cancer J. Clin. 2020. V. 70. P. 299–312. https://doi.org/10.3322/caac.21613
  5. Schuller H.M. // Nat. Rev. Cancer. 2009. V. 9. P. 195–205. https://doi.org/10.1038/nrc2590
  6. Egleton R.D., Brown K.C., Dasgupta P. // Trends Pharmacol. Sci. 2008. V. 29. P. 151–158. https://doi.org/10.1016/j.tips.2007.12.006
  7. Zoli M., Pucci S., Vilella A., Gotti C. // Curr. Neuropharmacol. 2018. V. 16. P. 338–349. https://doi.org/10.2174/1570159X15666170912110450
  8. Wessler I., Kirkpatrick C.J. // Br. J. Pharmacol. 2008. V. 154. P. 1558–1571. https://doi.org/10.1038/bjp.2008.185
  9. Grando S.A. // Nat. Rev. Cancer. 2014. V. 14. P. 419–429. https://doi.org/10.1038/nrc3725
  10. Tsurutani J., Castillo S.S., Brognard J., Granville C.A., Zhang C., Gills J.J., Sayyah J., Dennis P.A. // Carcinogenesis. 2005. V. 26. P. 1182–1195. https://doi.org/10.1093/carcin/bgi072
  11. Dasgupta P. // J. Clin. Invest. 2006. V. 116. P. 2208–2217. https://doi.org/10.1172/JCI28164
  12. Arredondo J., Chernyavsky A.I., Jolkovsky D.L., Pinkerton K.E., Grando S.A. // FASEB J. 2007. V. 22. P. 1356–1368. https://doi.org/10.1096/fj.07-9965com
  13. Wang S., Hu Y. // Oncol. Lett. 2018. V. 16. P. 1375–1382. https://doi.org/10.3892/ol.2018.8841
  14. Shulepko M.A., Bychkov M.L., Lyukmanova E.N., Kirpichnikov M.P. // Dokl. Biochem. Biophys. 2020. V. 493. P. 211–214. https://doi.org/10.1134/S1607672920040134
  15. Loughner C.L., Bruford E.A., McAndrews M.S., Delp E.E., Swamynathan S., Swamynathan S.K. // Hum. Genomics. 2016. V. 10. P. 10. https://doi.org/10.1186/s40246-016-0074-2
  16. Vasilyeva N.A., Loktyushov E.V., Bychkov M.L., Shenkarev Z.O., Lyukmanova E.N. // Biochemistry (Moscow). 2017. V. 82. P. 1702–1715. https://doi.org/10.1134/S0006297917130090
  17. Shulepko M.A., Kulbatskii D.S., Bychkov M.L., Lyukmanova E.N. // Russ. J. Bioorg. Chem. 2019. V. 45. P. 66–75. https://doi.org/10.1134/S1068162019020122
  18. Liu J.-F., Mao L., Bu L.-L., Ma S.-R., Huang C.-F., Zhang W.-F., Sun Z.-J. // Am. J. Cancer Res. 2015. V. 5. P. 3505–3515.
  19. Jacobsen B., Kriegbaum M.C., Santoni-Rugiu E., Ploug M. // World J. Clin. Oncol. 2014. V. 5. P. 621–632. https://doi.org/10.5306/wjco.v5.i4.621
  20. Choi S.H., Kong H.K., Park S.Y., Park J.H. // Int. J. Oncol. 2009. V. 35. P. 601–607. https://doi.org/10.3892/ijo_00000371
  21. Su S.-C., Lin C.-W., Yang W.-E., Fan W.-L., Yang S.-F. // Expert Opin. Ther. Targets. 2016. V. 20. P. 551–566. https://doi.org/10.1517/14728222.2016.1113260
  22. Fu X.W., Song P.F., Spindel E.R. // Int. Immunopharmacol. 2015. V. 29. P. 93–98. https://doi.org/10.1016/j.intimp.2015.05.022
  23. Reiter R.E., Gu Z., Watabe T., Thomas G., Szigeti K., Davis E., Wahl M., Nisitani S., Yamashiro J., Le Beau M.M. // Proc. Natl. Acad. Sci. USA. 1998. V. 95. P. 1735–1740. https://doi.org/10.1073/pnas.95.4.1735
  24. Bergqvist C., Kadara H., Hamie L., Nemer G., Safi R., Karouni M., Marrouche N., Abbas O., Hasbani D.J., Kibbi A.G. // Int. J. Dermatol. 2018. V. 57. P. 162–170. https://doi.org/10.1111/ijd.13850
  25. Russo P., Cardinale A., Margaritora S., Cesario A. // Life Sci. 2012. V. 91. P. 1087–1092. https://doi.org/10.1016/j.lfs.2012.05.003
  26. Throm V.M., Männle D., Giese T., Bauer A.S., Gaida M.M., Kopitz J., Bruckner T., Plaschke K., Grekova S.P., Felix K. // Oncotarget. 2018. V. 9. P. 11734–11751. https://doi.org/10.18632/oncotarget.24312
  27. Luo L., McGarvey P., Madhavan S., Kumar R., Gusev Y., Upadhyay G. // Oncotarget. 2016. V. 7. P. 11165–11193. https://doi.org/10.18632/oncotarget.7163
  28. Chernyavsky A.I., Arredondo J., Galitovskiy V., Qian J., Grando S.A. // Am. J. Physiol. Cell Physiol. 2010. V. 299. P. 903–911. https://doi.org/10.1152/ajpcell.00216.2010
  29. Pettersson A. Nylund G., Khorram-Manesh A., Nordgren S., Delbro D.S. // Auton. Neurosci. 2009. V. 148. P. 97–100. https://doi.org/10.1016/j.autneu.2009.03.002
  30. Arredondo J., Chernyavsky A.I., Grando S.A. // Life Sci. 2007. V. 80. P. 2243–2247. https://doi.org/10.1016/j.lfs.2007.01.003
  31. Lyukmanova E.N., Shulepko M.A., Kudryavtsev D.S., Bychkov M.L., Kulbatskii D.S., Kasheverov I.E., Astapova M.V., Feofanov A.V., Thomsen M.S., Mikkelsen J.D., Shenkarev Z.O., Tsetlin V.I., Dolgikh D.A., Kirpichnikov M.P. // PLoS One. 2016. V. 11. e0149733. https://doi.org/10.1371/journal.pone.0149733
  32. Lyukmanova E.N., Bychkov M.L., Sharonov G.V., Efremenko A.V., Shulepko M.A., Kulbatskii D.S., Shenkarev Z.O., Feofanov A.V., Dolgikh D.A., Kirpichnikov M.P. // Br. J. Pharmacol. 2018. V. 175. P. 1973–1986. https://doi.org/10.1111/bph.14194
  33. Lyukmanova E.N., Shulepko M.A. Bychkov M.L., Shenkarev Z.O., Paramonov A.S., Chugunov A.O., Arseniev A.S., Dolgikh D.A., Kirpichnikov M.P. // Acta Naturae. 2014. V. 6. P. 60–66.
  34. Shulepko M.A., Bychkov M.L., Shlepova O.V., Shenkarev Z.O., Kirpichnikov M.P., Lyukmanova E.N. // Int. Immunopharmacol. 2020. V. 82. P. 106303. https://doi.org/10.1016/j.intimp.2020.106303
  35. Bychkov M.L., Shulepko M.A., Shlepova O.V., Kulbatskii D.S., Chulina I.A., Paramonov A.S., Baidakova L.K., Azev V.N., Koshelev S.G., Kirpichnikov M.P., Shenkarev Z.O., Lyukmanova E.N. // Front. Cell Dev. Biol. 2021. V. 9. P. 739391. https://doi.org/10.3389/fcell.2021.739391
  36. Chernyavsky A.I., Shchepotin I.B., Grando S.A. // Int. Immunopharmacol. 2015. V. 29. P. 36–44. https://doi.org/10.1016/j.intimp.2015.05.033
  37. Kirichenko A.V., Shlepova O.V., Bychkov M.L., Mikhaylova I.N., Shulepko M.A., Lyukmanova E.N. // J. Invest. Dermatol. 2021. V. 141. P. 9. https://doi.org/10.1016/j.jid.2021.02.065
  38. Thompson E.G., Sontheimer H. // Cells. 2019. V. 8. P. 1203. https://doi.org/10.3390/cells8101203
  39. Kajstura M. Halicka H.D., Pryjma J., Darzynkiewicz Z. // Cytom. Part J. Int. Soc. Anal. Cytol. 2007. V. 71. P. 125–131. https://doi.org/10.1002/cyto.a.20357
  40. Bychkov M.L., Shenkarev Z.O., Shulepko M.A., Shlepova O.V., Kirpichnikov M.P., Lyukmanova E.N. // PLoS One. 2019. V. 14. P. e0217339. https://doi.org/10.1371/journal.pone.0217339
  41. Grave N., Scheffel T.B., Cruz F.F., Rockenbach L., Goettert M.I., Laufer S., Morrone F.B. // Front. Pharmacol. 2022. V. 13. P. 975197. https://doi.org/10.3389/fphar.2022.975197
  42. Chen D., Zuo D., Luan C., Liu M., Na M., Ran L., Sun Y., Persson A., Englund E., Salford L.G. // PLoS One. 2014. V. 9. P. e87281. https://doi.org/10.1371/journal.pone.0087281
  43. Zhang Z.-Q., Wang X., Xue B.-H., Zhao Y., Xie F., Wang S.-D., Xue C., Wang Y., Zhang Y.-S., Qian L.-J. // Oncol. Rep. 2021. V. 46. P. 202. https://doi.org/10.3892/or.2021.8153
  44. Pucci S., Fasoli F., Moretti M., Benfante R., Di Lascio S., Viani P., Daga, A., Gordon T.J., McIntosh M., Zoli M. // Pharmacol. Res. 2021. V. 163. P. 105336. https://doi.org/10.1016/j.phrs.2020.105336
  45. McConnell D.D., Carr S.B., Litofsky N.S. // Expert Rev. Neurother. 2019. V. 19. P. 545–555. https://doi.org/10.1080/14737175.2019.1617701
  46. Schildge S., Bohrer C., Beck K., Schachtrup C. // J. Vis. Exp. 2013. P. e50079. https://doi.org/10.3791/50079
  47. Shulepko M.A., Lyukmanova E.N., Paramonov A.S., Lobas A., Shenkarev Z.O., Kasheverov I.E., Dolgikh D.A., Tsetlin V.I., Arseniev A.S., Kirpichnikov M.P. // Biochemistry (Moscow). 2013. V. 78. P. 204–211. https://doi.org/10.1134/S0006297913020090

补充文件

附件文件
动作
1. JATS XML
下载
2.

下载 (34KB)
索引源数据
3.

下载 (574KB)
索引源数据
4.

下载 (527KB)
索引源数据
5.

下载 (127KB)
索引源数据

版权所有 © М.А. Шулепко, М.Л. Бычков, М.П. Кирпичников, Е.Н. Люкманова, 2023